US FDA Archives - Journal of Anaesthesia Practice

28 April 2020

US FDA approves Emerphed from Nexus Pharmaceuticals

The US Food and Drug Administration has approved Emerphed, the first and only premixed ephedrine in a ready-to-use 50 mg/10...

and receive all of the latest news via our weekly newsletter

"*" indicates required fields

BROWSE BY SECTION

ABOUT
ARTICLES
BOOK REVIEWS
COMPANIES
COMPANY INTERVIEWS
EDITORIAL BOARD
EVENTS
FEBRUARY 2024
JANUARY 2024
JULY 2024
MAY 2024
NEWS
NOVEMBER 2023
NOVEMBER 2024
OCTOBER 2023
PRODUCT NEWS
PROMOTIONAL FEATURES
SEPTEMBER 2023
SEPTEMBER 2024

About Us

Journal of Anaesthesia Practice is a leading online title in the field of anaesthesia

Journal of Anaesthesia Practice is a unique online vehicle for getting an anaesthetic product or service in front of the people who really matter. The vast majority of the readership are consultant anaesthetists.

US FDA

US FDA approves Emerphed from Nexus Pharmaceuticals

A rare intrathoracic vascular anomaly

Central Medical Supplies appoints new Account Managers

Precision pain management: Tailoring strategies to individual patient profiles

Anaesthetic implications of Aarskog-Scott syndrome

Delayed awakening after general anaesthesia and sedation

New analgesic could replace opioids over the long term

About Us

US FDA

US FDA approves Emerphed from Nexus Pharmaceuticals

and receive all of the latest news via our weekly newsletter

A rare intrathoracic vascular anomaly

Central Medical Supplies appoints new Account Managers

Precision pain management: Tailoring strategies to individual patient profiles

Anaesthetic implications of Aarskog-Scott syndrome

Delayed awakening after general anaesthesia and sedation

New analgesic could replace opioids over the long term

About Us

Subscribe

and receive all of the latest news via our weekly newsletter